Our results indicate that, following treatment with rifaximin, patients with MHE show a partial or total improvement in cognitive impairment associated with lower plasma levels of NfL, suggesting an enhancement in neuronal function in neurons undergoing decline. The gene discussed is NEFL; the disease is Cognitive impairment.